JP2000139842A - Dementia diagnosing system - Google Patents

Dementia diagnosing system

Info

Publication number
JP2000139842A
JP2000139842A JP10320368A JP32036898A JP2000139842A JP 2000139842 A JP2000139842 A JP 2000139842A JP 10320368 A JP10320368 A JP 10320368A JP 32036898 A JP32036898 A JP 32036898A JP 2000139842 A JP2000139842 A JP 2000139842A
Authority
JP
Japan
Prior art keywords
miosis
light
dementia
subject
miotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10320368A
Other languages
Japanese (ja)
Other versions
JP3992258B2 (en
Inventor
Ichiro Fukumoto
一朗 福本
Hisashi Uchiyama
尚志 内山
Gakubin Shi
学敏 史
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elmo Co Ltd
Original Assignee
Elmo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elmo Co Ltd filed Critical Elmo Co Ltd
Priority to JP32036898A priority Critical patent/JP3992258B2/en
Publication of JP2000139842A publication Critical patent/JP2000139842A/en
Application granted granted Critical
Publication of JP3992258B2 publication Critical patent/JP3992258B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To judge dementia with little burden without the danger of the side reaction of medicines by irradiating the eye of a testee with a light, detecting a miosis rate after a prescribed time elapses and judging imbecility in case the miosis rate is smaller than a prescribed value. SOLUTION: The eye of the testee is irradiated with a light from about 50 mm distance by the angle of about 45 deg. in an upper part. That is, a system is constituted of a light source 11, the pupil photographing infrared-ray camera 12 and an image analyzing computer 13 by considering that the light at the pupil becomes the sufficient one. An indication index 14 to be gazed by the testee under photographing is fitted to the infrared-ray camera 12. Then about 600-800 μw light with the wave length of light power meter 520 nm in light strength is irradiated to the pupil. The miosis rate after the prescribed time elapses is detected. Then the detected miosis rate is compared with the prescribed value together with the existence of cerebral cells or the like in a CT image so that presence or absence of dementia is decided. Thus it is decided without the danger of the side reaction of the medicines or the like.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、光刺激に対する縮瞳反
応が健常者と痴呆患者とで違うことを利用した、非侵襲
的な痴呆診断システムに関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a noninvasive diagnostic system for dementia utilizing the fact that miotic responses to light stimuli differ between healthy subjects and demented patients.

【0002】[0002]

【従来の技術】軽い痴呆を患っている老人の診断は非常
に困難である。病気によって生じる脳の病変を明らかに
するには脳の生検が有効だが、これは患者が死亡した後
でなければ決定的な診断は得られない。最近、アルツハ
イマー病(Alzheimer's disease、AD)の研究でいく
つか発見があり、新しい技術を使った、より確実な診断
が可能になりつつある。これらは病気の進行をモニター
するのにも都合がよく、効果的な治療薬の発見に役立つ
ことになるであろう。これらの方法の一つに、Scintoら
が研究を行っている、痴呆を早期にしかも簡単に診断で
きる点眼検査法がある(L. F. M. Scinto, K. R. Daffn
er, D. Dressler, B. I. Ransil, D. Rentz, S. Weintr
aub, M. Mesulam & H. Potter: A Potential noninvasi
ve neurobiological test for Alzheimer's disease, S
cience, 266, 1051/1054 (1994)及びWO96/030
70(日本国特表平10−503209)参照)。
2. Description of the Prior Art Diagnosis of an elderly man with mild dementia is very difficult. A biopsy of the brain is helpful in determining the pathology of the brain caused by the disease, but only after the patient has died can a definitive diagnosis be obtained. Recently, Alzheimer's disease (AD) has been discovered in some studies, and new technologies are making more accurate diagnosis possible. They are also convenient for monitoring the progress of the disease and will help find effective therapeutics. One of these methods is an eye drop test method that Scinto et al. Is studying, which can diagnose dementia early and easily (LFM Scinto, KR Daffn
er, D. Dressler, BI Ransil, D. Rentz, S. Weintr
aub, M. Mesulam & H. Potter: A Potential noninvasi
ve neurobiological test for Alzheimer's disease, S
cience, 266, 1051/1054 (1994) and WO 96/030.
70 (see Japanese Patent Publication No. Hei 10-503209).

【0003】ところで、視覚は外界の物体が眼の網膜上
に結像し、その像が光受容器によって検出され、視神経
を介して中枢に伝えられることによって起こる。そし
て、老化に伴い視覚に加齢変化が起こることが明らかに
なっている。瞳孔の大きさは瞳孔括約筋と瞳孔散大筋の
収縮により調節される。瞳孔括約筋は副交感神経に、瞳
孔散大筋は交感神経に支配されている。例えば、眼に入
る光の情報が増えると反射性に瞳孔が縮小するが、これ
は光の情報が視神経を介して中枢のEdinger-Westphal核
に伝えられ、そのEdinger-Westphal核の副交感神経節前
ニューロンの活動を反射性に増大させて瞳孔括約筋を収
縮させることによる。なお一般的に、光刺激に対する縮
瞳反応の潜時は加齢に伴い延長し、また瞳孔の大きさは
青年期より加齢に伴い漸次縮小する。さらに、光に対す
る瞳孔の収縮率も散大率も小さくなる。
[0003] Vision occurs when an external object forms an image on the retina of the eye, and the image is detected by a photoreceptor and transmitted to the center via the optic nerve. And it is clear that age-related changes occur in vision with aging. Pupil size is regulated by contraction of the pupillary sphincter and dilated pupil. The pupillary sphincter is controlled by the parasympathetic nerve, and the dilated pupil is controlled by the sympathetic nerve. For example, as the light information entering the eye increases, the pupil contracts reflexively, but this information is transmitted through the optic nerve to the central nucleus Edinger-Westphal nucleus, which is located in front of the parasympathetic ganglion of the Edinger-Westphal nucleus. By contracting the pupillary sphincter by reflexively increasing the activity of neurons. In general, the latency of the miotic response to light stimulation increases with age, and the size of the pupil gradually decreases with age from adolescence. Further, both the contraction rate and the divergence rate of the pupil with respect to light are reduced.

【0004】そこでScintoらの点眼検査法は、合成アト
ロピン類似物質であるトロピカミド(瞳孔散大薬の主な
成分)を点眼し、30分後に瞳孔の変化を観察してその
散瞳薬に対する過敏性の違いによりアルツハイマー病を
診断しようとするものである。
Thus, the eye drop test method of Scinto et al. Applied tropicamide (a major component of pupil dilator), which is a synthetic atropine analog, observed changes in the pupil 30 minutes later, and made the drug hypersensitive to the pupil. The purpose of this study is to diagnose Alzheimer's disease based on the differences.

【0005】[0005]

【発明が解決しようとする課題】しかしながら、薬物を
用いるこの方法には薬の副作用と危険性があり、適応患
者が制限される。また計測時間が長すぎるなどの問題点
があった。そこで本発明は、検査、診断システムにおけ
る簡便、無侵襲、無副作用の原則に基づき、光刺激に対
する瞳孔の変化率及び反応時間が健常者と痴呆患者とで
違うことを利用した新しい痴呆診断システムを提供する
ことを目的とする。
However, this method of using drugs has the side effects and risks of drugs, and limits the indication patients. There are also problems such as the measurement time being too long. Accordingly, the present invention provides a new dementia diagnosis system based on the principle of simple, non-invasive, and no side effects in a test and diagnosis system, which utilizes the fact that the rate of change of the pupil and the response time to light stimulation differ between healthy subjects and dementia patients. The purpose is to provide.

【0006】[0006]

【課題を解決するための手段】即ち本発明の第1番目の
痴呆診断システムは、被験者の眼に光を照射する光源
と、その光源から光を照射して所定時間経過後に前記被
験者の眼が縮瞳する縮瞳率を検出する縮瞳率検出手段
と、その縮瞳率検出手段によって検出された縮瞳率と所
定の値を比較して縮瞳率が所定の値より小さい場合に前
記被験者が痴呆であると判定する第1判定手段とからな
ることを特徴とする。また本発明の第2番目の痴呆診断
システムは、被験者の眼に光を照射する光源と、その光
源から光を照射して前記被験者の眼が最大に縮瞳するま
での縮瞳時間を検出する縮瞳時間検出手段と、その縮瞳
時間検出手段によって検出された縮瞳時間と所定の値を
比較して縮瞳時間が所定の値より長い場合に前記被験者
が痴呆であると判定する第2判定手段とからなることを
特徴とする。さらに本発明の第3番目の痴呆診断システ
ムは、被験者の眼に光を照射する光源と、その光源から
光を照射して所定時間経過後に前記被験者の眼が縮瞳す
る縮瞳率を検出する縮瞳率検出手段と、該光源から光を
照射して前記被験者の眼が最大に縮瞳するまでの縮瞳時
間を検出する縮瞳時間検出手段と、前記縮瞳率検出手段
によって検出された縮瞳率と所定の値を比較して縮瞳率
が所定の値より小さい場合及び前記縮瞳時間検出手段に
よって検出された縮瞳時間と所定の値を比較して縮瞳時
間が所定の値より長い場合の少なくとも一方の場合に前
記被験者が痴呆であると判定する第3判定手段とからな
ることを特徴とする。
That is, a first system for diagnosing dementia according to the present invention comprises: a light source for irradiating light to a subject's eye; A miotic ratio detecting means for detecting a miotic ratio to be mimicked, and comparing the miotic ratio detected by the miotic ratio detecting device with a predetermined value. Comprises first determining means for determining that the patient has dementia. Further, a second dementia diagnosis system of the present invention detects a light source for irradiating light to a subject's eye, and a miosis time until the subject's eye is maximally miotic by irradiating light from the light source. A second step of comparing the miosis time detected by the miosis time detection means with a predetermined value and determining that the subject has dementia if the miosis time is longer than a predetermined value; And determining means. Further, the third dementia diagnosis system of the present invention detects a light source for irradiating light to the subject's eye and a miotic ratio at which the subject's eye mimics after a predetermined time after irradiating the light from the light source. Miosis rate detection means, miosis time detection means for irradiating light from the light source to detect miosis time until the subject's eye is maximally miotic, and miosis rate detection means When the miosis rate is smaller than a predetermined value by comparing the miosis rate with a predetermined value, and the miosis time detected by the miosis time detecting means is compared with a predetermined value, and the miosis time is a predetermined value. A third determination unit that determines that the subject has dementia in at least one of the longer cases.

【0007】[0007]

【作用・効果】本発明の痴呆診断システムによれば、光
刺激に対しアルツハイマー型痴呆などの痴呆患者と健常
高齢者との間に明かな縮瞳率及び縮瞳時間の違いがある
ことを利用して被験者の痴呆の有無を判定することがで
きる。即ち、第1番目の痴呆診断システムによれば、被
験者の眼に光を照射して所定時間経過後の縮瞳率を所定
の値(ほぼ同年齢の健常者の縮瞳率)と比較してその縮
瞳率が所定の値より小さい場合にその被験者が痴呆であ
ると判定することができる。また第2番目の痴呆診断シ
ステムによれば、被験者の眼に光を照射してその被験者
の眼が最大に縮瞳するまでの縮瞳時間を所定の値(ほぼ
同年齢の健常者の縮瞳時間)と比較してその縮瞳時間が
所定の値より長い場合にその被験者が痴呆であると判定
することができる。さらに第3番目の痴呆診断システム
では、縮瞳率と縮瞳時間の両方を検出できるように構成
されているため、そのいずれか一方がほぼ同年齢の健常
者の所定の値と有意に差がある場合に痴呆と判定すれば
よい。さらにこのシステムでその両方が各所定の値と有
意に差がある場合は痴呆の判定の信頼性がより高いと判
断することができる。
According to the system for diagnosing dementia of the present invention, the fact that there is a clear difference in miosis rate and miosis time between a dementia patient such as Alzheimer-type dementia and a healthy elderly person in response to light stimulation is used. Thus, the presence or absence of dementia in the subject can be determined. That is, according to the first system for diagnosing dementia, the miosis rate after a predetermined period of time has elapsed by irradiating light to the subject's eye is compared with a predetermined value (the miosis rate of a healthy person of substantially the same age). If the miosis rate is smaller than a predetermined value, it can be determined that the subject has dementia. According to the second system for diagnosing dementia, the miosis time until the subject's eye is maximally miotic by irradiating light to the subject's eye is set to a predetermined value (the miosis of a healthy person of substantially the same age). The subject can be determined to have dementia if the miosis time is longer than a predetermined value as compared with (time). Further, the third system for diagnosing dementia is configured to be able to detect both the miosis rate and the miosis time, so that either one of them is significantly different from a predetermined value of a healthy person of almost the same age. In some cases, it may be determined as dementia. Further, in this system, when both of them are significantly different from the respective predetermined values, it can be determined that the reliability of the determination of dementia is higher.

【0008】[0008]

【実施例】以下、図面に基づき本発明の痴呆診断システ
ム及びそれを用いた診断方法を詳細に説明する。 A.システム構成 本発明のシステムの構成図を図1に示す。このシステム
は、正面上方45°の角度から50mmの距離より被験
者の眼に光を照射し、その瞳孔での光が充分となるよう
に配慮して市販のペンライト(商品名:National BF-51
1)を改良した光源11と、被験者の眼から40mmの
距離に置かれ、瞳孔の様子を撮影する赤外線カメラ(CS
3450, TYPE BV6309A3(TOKYO ELECTRONIC INDUSTRY CO.,
LTD製))12と、その赤外線カメラから得られる画像
を解析するコンピュータ(Macintosh 7600)13とから
なる。そして瞳孔径は注視点までの距離によって変化す
るため、赤外線カメラ12に固定して、被験者が撮影中
に注視する目標である提示指標14が取り付けられてい
る。ここではカメラの長さが175mmであり、提示指
標14はそのカメラの後ろの横60mmの位置に配設さ
れている。また被験者の眼に入光する光の光強度を定量
的に測定するために光パワーメーター(Advantest, TQ
8210)15も設置されている。赤外線カメラ12で撮影
された画像は、コンピュータ13に搭載した画像処理用
ソフト(Apple ビデオプレーヤ、MediaGrabber, Graphi
c Converter 2.9.1)により処理されてディスプレイに
表示される。
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a block diagram showing a system for diagnosing dementia according to the present invention; A. 1. System Configuration FIG. 1 shows a configuration diagram of the system of the present invention. This system irradiates the subject's eye with light from a distance of 50 mm from an angle of 45 ° from the front and a commercially available penlight (trade name: National BF-51) in consideration of sufficient light in the pupil.
1) An improved light source 11 and an infrared camera (CS) placed at a distance of 40 mm from the subject's eyes
3450, TYPE BV6309A3 (TOKYO ELECTRONIC INDUSTRY CO.,
LTD) 12) and a computer (Macintosh 7600) 13 for analyzing images obtained from the infrared camera. Since the pupil diameter changes depending on the distance to the point of gaze, the pupil diameter is fixed to the infrared camera 12, and a presentation index 14, which is a target to be watched by the subject during imaging, is attached. Here, the length of the camera is 175 mm, and the presentation index 14 is arranged at a position 60 mm horizontally behind the camera. An optical power meter (Advantest, TQ) is used to quantitatively measure the light intensity of the light entering the subject's eye.
8210) 15 are also installed. Images captured by the infrared camera 12 are processed by image processing software (Apple video player, MediaGrabber, Graphi
c Processed by Converter 2.9.1) and displayed on the display.

【0009】B.測定条件 B.1.光強度 光源状態に応じた光強度を「表1」に示す。B. Measurement conditions B. 1. Light intensity The light intensity according to the light source state is shown in "Table 1".

【0010】[0010]

【表1】 [Table 1]

【0011】「表1」に示すように、瞳孔に照射する光
強度は光パワーメーター520nmの波長において60
0〜800μwで一定であった。
As shown in Table 1, the light intensity applied to the pupil is 60 at the wavelength of the optical power meter 520 nm.
It was constant from 0 to 800 μw.

【0012】B.2.被験者 被験者は次の「表2」に示す108人を対象とした。B. 2. Subjects The subjects were 108 subjects shown in the following “Table 2”.

【0013】[0013]

【表2】 [Table 2]

【0014】痴呆の有無評価及び痴呆の鑑別は、CT画
像における脳細胞の萎縮の有無、発病の状況や年齢、進
行のしかた、現在の脳機能の障害などの症状、脳血管性
疾患の有無や高血圧、動脈硬化などとの関連性の既往
歴、長谷川式簡易知能評価スケール、MMS、三宅式記
銘力検査などの結果を総合的に判断してなされた。原則
として被験者は左目のみを計測(失明、手術等で計測不
可能の場合には代わりに右目を計測)した。コンタクト
レンズを使用している被験者は装着したままで、また眼
鏡をしている被験者は裸眼で計測した。 C.測定手順 測定はまず、本発明のシステムが視力の違いによらず有
効であるということを確認するために、健常学生を被験
者として予備測定を行った。有効性を確認した後、健常
高齢者、痴呆患者を被験者として測定を行った。瞳孔の
大きさ及び縮瞳時間を測定するための具体的な測定手順
のフローは図2に示す通りである。即ち、赤外線カメラ
での撮影は室内光の状態で始まり(ステップ21)、5
秒後に光源がオン(ステップ22)になる。そして5秒
間光が照射された後、光源がオフ(ステップ23)にな
る。撮影は光源がオフになった5秒後まで続けられ、合
計15秒間で撮影が終了する(ステップ24)。なお被
験者には特別な姿勢をとることは要求せず、測定中は提
示指標を見るように指示した。
The evaluation of the presence or absence of dementia and the differentiation of dementia include the presence or absence of atrophy of brain cells in CT images, the onset and age of the disease, the manner of progression, symptoms such as current cerebral dysfunction, and the presence or absence of cerebrovascular disease. The results were comprehensively determined based on the history of association with hypertension, arteriosclerosis, etc., the Hasegawa-type simplified intelligence evaluation scale, MMS, and the Miyake-type memorization test. In principle, the subject measured only the left eye (if measurement was impossible due to blindness, surgery, etc., the right eye was measured instead). The subjects wearing contact lenses were measured while wearing them, and the subjects wearing spectacles were measured with the naked eye. C. Measurement Procedure The measurement was first performed with healthy students as subjects to confirm that the system of the present invention was effective irrespective of differences in visual acuity. After confirming the efficacy, the measurement was performed using healthy elderly people and dementia patients as subjects. The flow of a specific measurement procedure for measuring the pupil size and the miosis time is as shown in FIG. That is, the photographing with the infrared camera starts in the state of room light (step 21).
After a second, the light source is turned on (step 22). Then, after the light is irradiated for 5 seconds, the light source is turned off (step 23). The photographing is continued until 5 seconds after the light source is turned off, and the photographing is completed in a total of 15 seconds (step 24). The subject was not required to take a special posture, and was instructed to look at the presented index during the measurement.

【0015】D.解析方法 D.1.瞳孔の大きさの計測 赤外線カメラで撮影された画像はコンピュータに取り込
まれて処理され、ディスプレイに処理画像として表示さ
れた。瞳孔の大きさはこのコンピュータ処理画像のピク
セル単位で直径のみを読み取った。図3に示すようなコ
ンピュータ処理画面は320×240ピクセルと設定し
た。また画像処理ソフトは1/30秒毎の画像を取り扱
うことが可能であることから、この精度で解析を行っ
た。図3の(a)及び(b)はそれぞれ室内光状態での
瞳孔と光源オン状態での瞳孔の計測例を示している。
D.2.瞳孔縮瞳曲線 こうして0.03秒ずつ5秒間、計150枚からなる被
験者の瞳孔のコンピュータ処理画像について瞳孔直径を
計測し、それから瞳孔の収縮率を次の「数1」にしたが
って算出することで瞳孔収縮曲線を得、その一例を図4
に示す。
D. Analysis method D. 1. Measurement of pupil size Images captured by the infrared camera were captured by a computer, processed, and displayed on the display as processed images. The pupil size was read only in diameter in pixels of this computerized image. The computer processing screen as shown in FIG. 3 was set to 320 × 240 pixels. Since the image processing software can handle an image every 1/30 second, the analysis was performed with this accuracy. FIGS. 3A and 3B show measurement examples of the pupil in the indoor light state and the pupil in the light source on state, respectively.
D. 2. Pupil miosis curve In this way, the pupil diameter is measured for a computer-processed image of the subject's pupil consisting of a total of 150 subjects for 0.03 seconds for 5 seconds, and then the pupil contraction rate is calculated according to the following “Equation 1”. The pupil contraction curve was obtained, an example of which is shown in FIG.
Shown in

【0016】[0016]

【数1】 (Equation 1)

【0017】この図4に示されているように、光刺激に
対する瞳孔の収縮率において、最小に瞳孔が収縮した際
の収縮率(最大収縮率)を縮瞳率1、また光源がオンに
なってから5秒後(瞳孔の対光反応が終わった後の安定
時)の瞳孔の収縮率を縮瞳率2とし、それぞれの縮瞳率
を「数2」及び「数3」に示すように定義した。
As shown in FIG. 4, in the pupil contraction rate with respect to the light stimulus, the contraction rate (maximum contraction rate) when the pupil is contracted to the minimum is 1 and the light source is turned on. The pupil contraction rate after 5 seconds from the end of the pupil (when the pupil is stable after the light response is completed) is defined as the miotic ratio 2, and the respective miotic ratios are shown in "Equation 2" and "Equation 3". Defined.

【0018】[0018]

【数2】 (Equation 2)

【0019】[0019]

【数3】 (Equation 3)

【0020】また縮瞳時間は、「光源オンから瞳孔が最
小に収縮するまでの時間」と定義した。 E.測定結果 E.1.健常学生による視力と縮瞳率との関係 各健常学生の視力に対する縮瞳率2を次の「表3」に示
す。この「表3」においてA、B、C、及びD組はそれ
ぞれ、視力が0.5以下、0.5から1.0、1.0以
上、及びコンタクトレンズ装着者である。
The miosis time is defined as "the time from turning on the light source until the pupil contracts to the minimum". E. FIG. Measurement results 1. Relationship between visual acuity of normal students and miosis rate The following Table 3 shows the miosis rate 2 with respect to visual acuity of each healthy student. In Table 3, sets A, B, C, and D are those having a visual acuity of 0.5 or less, 0.5 to 1.0, 1.0 or more, and a contact lens wearer, respectively.

【0021】[0021]

【表3】 [Table 3]

【0022】上記の「表3」より、検定を行った結果、
各視力グループ間で有為な差はなく、本発明の診断シス
テムによって得られる測定結果は被験者の視力によらず
一定であることが確かめられた。
From the above "Table 3", as a result of performing the test,
There was no significant difference between the visual acuity groups, and it was confirmed that the measurement results obtained by the diagnostic system of the present invention were constant irrespective of the visual acuity of the subject.

【0023】E.2.各被験者グループの瞳孔収縮曲線 各被験者グループについてコンピュータ処理画像から算
出した瞳孔の収縮率の平均値をプロットして得られたそ
れぞれの瞳孔収縮曲線を図5に示す。この図より、健常
高齢者に比べ痴呆患者は縮瞳率が小さく、また縮瞳時間
も長い(遅い)ことがわかる。 E.3.縮瞳率1 図6は各被験者グループの平均縮瞳率1を示している。
t検定の結果、健常高齢者とアルツハイマー型痴呆患者
及び脳血管性痴呆患者との間で縮瞳率1は危険率p<
0.05で有為な差が見られた。 E.4.縮瞳率2 各被験者グループの平均縮瞳率2の結果を図7に示す。
t検定の結果、健常高齢者とアルツハイマー型痴呆患者
との間で縮瞳率2は危険率p<0.05で有為な差が見
られた。 E.5.縮瞳時間 図8は各被験者グループの平均縮瞳時間の結果を示して
いる。健常高齢者とアルツハイマー型痴呆患者との間の
縮瞳時間についてのt検定の結果は、危険率p<0.0
1、また健常高齢者と脳血管性痴呆患者との間のその結
果は、危険率p<0.05で有意な差が見られた。 E.6.痴呆疾患間の鑑別 アルツハイマー型痴呆と脳血管性痴呆、またその他の痴
呆(精神分裂病後遺症痴呆など)を比較したが、縮瞳率
1、2及び縮瞳時間のいずれに対しても有為な差がみら
れなかった。 E.7.健常高齢者と学生の比較 健常高齢者は学生より縮瞳率が小さかったが、有為な差
は認められなかった。
E. 2. Pupil contraction curve of each subject group FIG. 5 shows each pupil contraction curve obtained by plotting the average value of the pupil contraction rate calculated from the computer-processed image for each subject group. From this figure, it can be seen that a dementia patient has a smaller miosis rate and a longer (slower) miosis time than a healthy elderly person. E. FIG. 3. FIG. 6 shows an average miosis rate 1 of each subject group.
As a result of the t-test, the miosis rate 1 between the healthy elderly person and the Alzheimer's type dementia patients and cerebrovascular dementia patients showed a risk rate p <
A significant difference was seen at 0.05. E. FIG. 4. Miosis rate 2 FIG. 7 shows the results of the average miosis rate 2 for each subject group.
As a result of the t-test, a significant difference was found between the healthy elderly person and the Alzheimer-type dementia patient with a miosis rate of 2 at a risk rate of p <0.05. E. FIG. 5. FIG. 8 shows the results of the average miosis time of each subject group. The results of the t-test on the miotic time between healthy elderly people and Alzheimer's dementia patients show that the risk factor p <0.0
1, and the results between healthy elderly and cerebrovascular dementia patients showed a significant difference with a risk factor p <0.05. E. FIG. 6. Differentiation between dementia diseases Alzheimer's type dementia was compared with cerebrovascular dementia and other dementias (sequence dementia of schizophrenia, etc.). No difference was seen. E. FIG. 7. Comparison of healthy elderly people and students Healthy elderly people had lower miosis than students, but no significant difference was observed.

【0024】F.実施例の変形 上記の実施例において、光源11のオン−オフを切り換
える切り換え手段、赤外線カメラ12で撮影した画像を
画像処理する画像処理手段、及びタイマをプログラムに
したがってマイクロプロセッサが制御することにより、
図2に示す測定フローを進行させるようにしてもよい。
さらに上記の実施例では、ディスプレイに表示されたコ
ンピュータ処理画像を手作業によって解析しているが、
その画像データに基づいて瞳孔面積を計算する瞳孔面積
計算手段、縮瞳率を計算する計算手段、及び縮瞳時間を
計算する計算手段を設け、プログラムに従ってコンピュ
ータのマイクロプロセッサがそれらの手段を制御して順
次各ステップを実行させるとともに、各手段より得られ
るパラメータを判定し、その判定結果を表示できるよう
にして、コンピュータ制御による自動的な診断システム
に構成してもよい。
F. Modification of Embodiment In the above embodiment, the microprocessor controls the switching means for switching the light source 11 on and off, the image processing means for performing image processing on an image captured by the infrared camera 12, and the timer according to a program.
The measurement flow shown in FIG. 2 may be advanced.
Further, in the above embodiment, the computer-processed image displayed on the display is analyzed manually,
A pupil area calculating means for calculating a pupil area based on the image data, a calculating means for calculating a miotic ratio, and a calculating means for calculating a miotic time, and a microprocessor of a computer controls the means according to a program. Each step may be sequentially executed, and the parameters obtained by each means may be determined, and the results of the determination may be displayed so as to constitute an automatic diagnosis system controlled by a computer.

【0025】[0025]

【発明の効果】本発明の痴呆診断システムによれば、光
刺激に対しアルツハイマー型痴呆などの痴呆患者と健常
高齢者との間に明かな縮瞳率及び縮瞳時間の違いがある
ことを利用して被験者の痴呆の有無を判定することがで
きる。したがってこの痴呆診断システムはアルツハイマ
ー型痴呆を含む痴呆を早期に診断することを可能にし、
その取り扱いが簡便で短時間で診断できることから一般
的な健康診断などでも使用できる。また無侵襲で、副作
用がなく、適応患者を制限することもない。
According to the system for diagnosing dementia of the present invention, the fact that there is a clear difference in miosis rate and miosis time between a dementia patient such as Alzheimer-type dementia and a healthy elderly person in response to light stimulation is used. Thus, the presence or absence of dementia in the subject can be determined. Therefore, this dementia diagnosis system enables early diagnosis of dementia including Alzheimer-type dementia,
Since it is easy to handle and can be diagnosed in a short time, it can be used for general health examinations and the like. It is non-invasive, has no side effects, and does not limit the indications for patients.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 本発明の痴呆診断システムの構成を示す概略
図である。
FIG. 1 is a schematic diagram showing the configuration of a dementia diagnosis system of the present invention.

【図2】 本発明の痴呆診断システムを用いて瞳孔の大
きさ及び縮瞳時間を測定する測定手順を示すフローであ
る。
FIG. 2 is a flowchart showing a measurement procedure for measuring a pupil size and a miosis time using the dementia diagnosis system of the present invention.

【図3】 (a)及び(b)は、それぞれ室内光状態で
の瞳孔と光源オン状態での瞳孔の計測例を模式的に示す
説明図である。
FIGS. 3A and 3B are explanatory diagrams schematically showing measurement examples of a pupil in an indoor light state and a pupil in a light source on state, respectively.

【図4】 本発明の痴呆診断システムを用いて得られる
コンピュータ処理画像から瞳孔の収縮率を算出して得ら
れる瞳孔縮瞳曲線の一例を示すグラフである。
FIG. 4 is a graph showing an example of a pupil miosis curve obtained by calculating a pupil contraction rate from a computer-processed image obtained by using the dementia diagnosis system of the present invention.

【図5】 本発明の痴呆診断システムを用いて得られる
コンピュータ処理画像から被験者グループ毎に算出した
瞳孔の収縮率の平均値をプロットして得られたそれぞれ
の瞳孔収縮曲線を示すグラフである。
FIG. 5 is a graph showing each pupil contraction curve obtained by plotting an average value of pupil contraction rates calculated for each subject group from a computer-processed image obtained using the dementia diagnosis system of the present invention.

【図6】 各被験者グループの平均縮瞳率1を示す棒グ
ラフである。
FIG. 6 is a bar graph showing an average miosis rate 1 of each subject group.

【図7】 各被験者グループの平均縮瞳率2を示す棒グ
ラフである。
FIG. 7 is a bar graph showing the average miosis rate 2 of each subject group.

【図8】 各被験者グループの平均縮瞳時間を示す棒グ
ラフである。
FIG. 8 is a bar graph showing the average miosis time of each subject group.

【符号の説明】[Explanation of symbols]

11…光源、12…赤外線カメラ、13…コンピュー
タ、14…提示指標、15…光パワーメーター。
11 ... light source, 12 ... infrared camera, 13 ... computer, 14 ... presentation index, 15 ... optical power meter.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 被験者の眼に光を照射する光源と、その
光源から光を照射して所定時間経過後に前記被験者の眼
が縮瞳する縮瞳率を検出する縮瞳率検出手段と、その縮
瞳率検出手段によって検出された縮瞳率と所定の値を比
較して縮瞳率が所定の値より小さい場合に前記被験者が
痴呆であると判定する第1判定手段とからなることを特
徴とする痴呆診断システム。
1. A light source for irradiating light to a subject's eye, a miotic ratio detecting means for detecting a miotic ratio at which the subject's eye contracts after a predetermined time has elapsed after irradiating the light from the light source, A first determination unit that compares the miosis ratio detected by the miosis ratio detection unit with a predetermined value and determines that the subject has dementia when the miosis ratio is smaller than a predetermined value. Dementia diagnostic system.
【請求項2】 被験者の眼に光を照射する光源と、その
光源から光を照射して前記被験者の眼が最大に縮瞳する
までの縮瞳時間を検出する縮瞳時間検出手段と、その縮
瞳時間検出手段によって検出された縮瞳時間と所定の値
を比較して縮瞳時間が所定の値より長い場合に前記被験
者が痴呆であると判定する第2判定手段とからなること
を特徴とする痴呆診断システム。
2. A light source for irradiating light to a subject's eye, a miosis time detecting means for irradiating light from the light source and detecting a miosis time until the subject's eye is maximally miotic. A second determining unit that compares the miotic period detected by the miotic period detecting unit with a predetermined value and determines that the subject has dementia when the miotic period is longer than a predetermined value. Dementia diagnostic system.
【請求項3】 被験者の眼に光を照射する光源と、その
光源から光を照射して所定時間経過後に前記被験者の眼
が縮瞳する縮瞳率を検出する縮瞳率検出手段と、該光源
から光を照射して前記被験者の眼が最大に縮瞳するまで
の縮瞳時間を検出する縮瞳時間検出手段と、前記縮瞳率
検出手段によって検出された縮瞳率と所定の値を比較し
て縮瞳率が所定の値より小さい場合及び前記縮瞳時間検
出手段によって検出された縮瞳時間と所定の値を比較し
て縮瞳時間が所定の値より長い場合の少なくとも一方の
場合に前記被験者が痴呆であると判定する第3判定手段
とからなることを特徴とする痴呆診断システム。
A light source for irradiating the subject's eye with light; and a miotic ratio detecting means for detecting a miotic ratio of the subject's eye mimicking after a predetermined time from irradiating the light from the light source; A miosis time detecting means for irradiating light from a light source and detecting a miosis time until the subject's eye is maximally miotic, and a miotic rate detected by the miotic rate detecting means and a predetermined value. At least one of a case where the miosis rate is smaller than a predetermined value and a case where the miosis time is longer than a predetermined value by comparing the miosis time detected by the miosis time detecting means with a predetermined value. And a third determining means for determining that the subject has dementia.
JP32036898A 1998-11-11 1998-11-11 Dementia diagnosis system Expired - Fee Related JP3992258B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP32036898A JP3992258B2 (en) 1998-11-11 1998-11-11 Dementia diagnosis system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32036898A JP3992258B2 (en) 1998-11-11 1998-11-11 Dementia diagnosis system

Publications (2)

Publication Number Publication Date
JP2000139842A true JP2000139842A (en) 2000-05-23
JP3992258B2 JP3992258B2 (en) 2007-10-17

Family

ID=18120707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP32036898A Expired - Fee Related JP3992258B2 (en) 1998-11-11 1998-11-11 Dementia diagnosis system

Country Status (1)

Country Link
JP (1) JP3992258B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111295128A (en) * 2017-10-30 2020-06-16 威里利生命科学有限责任公司 Active visual alignment stimulation in fundus photography

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111295128A (en) * 2017-10-30 2020-06-16 威里利生命科学有限责任公司 Active visual alignment stimulation in fundus photography
CN111295128B (en) * 2017-10-30 2022-08-19 威里利生命科学有限责任公司 Active visual alignment stimulation in fundus photography
US11844573B2 (en) 2017-10-30 2023-12-19 Verily Life Sciences Llc Active visual alignment stimuli in fundus photography

Also Published As

Publication number Publication date
JP3992258B2 (en) 2007-10-17

Similar Documents

Publication Publication Date Title
US11903720B2 (en) System and method for detecting neurological disease
US6231187B1 (en) Method and apparatus for detecting eye movement
WO2019015567A1 (en) Brain function testing system and device thereof
JP2009515568A (en) Apparatus and method for the diagnosis of optically distinguishable ophthalmic symptoms
JP2005131393A (en) Device and method for diagnosing ocular symptom which can optically be discriminated
Haque et al. VisMET: a passive, efficient, and sensitive assessment of visuospatial memory in healthy aging, mild cognitive impairment, and Alzheimer's disease
JP7166473B2 (en) eye examination
US11642068B2 (en) Device and method to determine objectively visual memory of images
Schiefer et al. Reaction time in automated kinetic perimetry: effects of stimulus luminance, eccentricity, and movement direction
Satgunam et al. Pediatric perimeter—a novel device to measure visual fields in infants and patients with special needs
WO2018035312A1 (en) Systems and methods for assessment of ocular cyclotorsion
RU2480142C2 (en) Device and method of remote evaluation of human visual analyser characteristics and carrying out training exercises for development of binocular and higher visual functions
US10485466B2 (en) Device and method for measuring mild perceptual impairment
EP3402388B1 (en) System and method for performing objective perimetry and diagnosis of patients with retinitis pigmentosa and other ocular diseases
US20210068650A1 (en) Assessing visual function
Maruthy et al. Quantitative determination of pupil by dynamic pupillometry using infrared videography–Role in evaluation of autonomic activity
JP2000139842A (en) Dementia diagnosing system
Summa et al. A wearable video-oculography based evaluation of saccades and respective clinical correlates in patients with early onset ataxia
Leite et al. Evaluation of ocular versions in Graves’ orbitopathy: correlation between the qualitative clinical method and the quantitative photographic method
Meethal et al. Detection of visual field defects using Eye Movement Pediatric Perimetry in children with intracranial lesions: feasibility and applicability
US20240081636A1 (en) Method for Visual Function Assessment Using Multistable Rivalry Paradigms
RU2753743C1 (en) Method for determining visual functions in preverbal children
Sandeep et al. Early prediction of Alzheimer’s disease by examining changes in eye parameters
Torii et al. Real Time Measurement and Processing of Pupillary Light Reflex for Early Detection of Disease.
Dalai et al. Applications of Eye Tracking in the Diagnosis of Early Stages of Autism Spectrum Disorders.

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 19981209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051028

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20051104

A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20051028

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20051104

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20051110

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060116

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20070626

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070717

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070723

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100803

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110803

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110803

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120803

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees